Trial
NCT05858515
REVERSE-Long COVID-19 With Baricitinib Study
Phase IIIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Vanderbilt University Medical Center
Collaborators
Emory University; University of California, San Francisco; University of Minnesota; Vanderbilt University; Yale University
Condition
Post-Acute COVID-19 Syndrome
Intervention
Baricitinib 4 MG
Why stopped
This submission for the pilot study has been withdrawn as the full trial opened under a different NCT number before participants enrolled in the pilot.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-01-31